These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6788612)

  • 1. Suppression of spermatogenesis in patients with Behçet's disease treated with cyclophosphamide and colchicine.
    Fukutani K; Ishida H; Shinohara M; Minowada S; Niijima T; Hijikata K; Izawa Y
    Fertil Steril; 1981 Jul; 36(1):76-80. PubMed ID: 6788612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of colchicine treatment on sperm production and function: a review.
    Haimov-Kochman R; Ben-Chetrit E
    Hum Reprod; 1998 Feb; 13(2):360-2. PubMed ID: 9557838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urological evaluation of Behçet patients and the effect of colchicine on fertility.
    Sarica K; Süzer O; Gürler A; Baltaci S; Ozdiler E; Dinçel C
    Eur Urol; 1995; 27(1):39-42. PubMed ID: 7744140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
    Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
    Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of testosterone to prevent cyclophosphamide-induced azoospermia.
    Masala A; Faedda R; Alagna S; Satta A; Chiarelli G; Rovasio PP; Ivaldi R; Taras MS; Lai E; Bartoli E
    Ann Intern Med; 1997 Feb; 126(4):292-5. PubMed ID: 9036801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Behçet's syndrome with colchicine].
    Pacor ML; Nicolis F; Peroli P; Urbani G; Cortina P; Corrocher R; Lunardi C
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):257-61. PubMed ID: 2640046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia.
    Ozdogu H; Boga C; Yilmaz Z; Sahin FI; Bal N
    Rheumatol Int; 2007 Jun; 27(8):763-5. PubMed ID: 17177066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pseudotumorous presentation of neuro-Behçet: role of the withdrawal of colchicine?].
    Vignes S; Vidailhet M; Dormont D; Soulié J; Wechsler B
    Rev Med Interne; 1998 Jan; 19(1):55-9. PubMed ID: 9775117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term effects of cyclophosphamide on testicular function.
    Watson AR; Rance CP; Bain J
    Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1457-60. PubMed ID: 3933709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
    Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
    J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine in the treatment of the cutaneous manifestations of Behçet's disease.
    Miyachi Y; Taniguchi S; Ozaki M; Horio T
    Br J Dermatol; 1981 Jan; 104(1):67-9. PubMed ID: 7459271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
    Hazen PG; Michel B
    Arch Dermatol; 1979 Nov; 115(11):1303-6. PubMed ID: 507883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine and testicular function in man.
    Bremner WJ; Paulsen CA
    N Engl J Med; 1976 Jun; 294(25):1384-5. PubMed ID: 1264178
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
    Ataş H; Cemil BC; Canpolat F; Gönül M
    Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty.
    Lentz RD; Bergstein J; Steffes MW; Brown DR; Prem K; Michael AF; Vernier RL
    J Pediatr; 1977 Sep; 91(3):385-94. PubMed ID: 894406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.